期刊文献+

心理干预联合药物对吸烟者的戒烟效果评价 被引量:7

Effectiveness of Varenicline with counseling programs on smoking cessation in a targeted clinical setting in China
原文传递
导出
摘要 目的 评价伐尼克兰在临床实践中对戒烟门诊患者戒烟的有效性.方法 采用前瞻性观察性研究设计,选择符合纳入标准的吸烟者799人,每名患者首诊时进行标准的基线问卷评估,并在第1、第3和第6个月进行随访.由经过培训的医师对每名患者完成面对面的咨询和个体化戒烟干预.接受药物辅助戒烟者定为心理干预联合药物组(n=272),未用药者为单纯心理干预组(n=527).采用意向性分析的统计学方法分析比较两组的7天时点戒烟率、3个月随访时的1个月持续戒烟率和6个月随访时的3个月持续戒烟率.结果 6个月随访时,心理干预联合药物组的7天时点戒烟率显著高于单纯心理干预组(34.6%vs.23.1%;OR=1.75,95% CI:1.27 ~ 2.42;P<0.001),心理干预联合药物组的3个月持续戒烟率也显著高于单纯心理干预组(31.3%vs.18.2%; OR=2.04,95%CI:1.46 ~ 2.86;P<0.001).1和3个月随访时,心理干预联合药物组无论是7天时点戒烟率还是1个月持续戒烟率均高于单纯心理干预组.结论 在真实临床实践的戒烟门诊中,给予戒烟者药物辅助戒烟可有效提高戒烟率. Objective To evaluate the effectiveness of Varenicline for smoking cessation in a community-based smoking-cessation-clinic (SCC) in Chinese smokers.Methods A prospective observational study was conducted in Beijing,China.799 smokers (762 men and 37 women) were assessed on data gathered from structured questionnaires at baseline and follow up programs at 1,3 and 6 months.Trained physician counselors provided free individual counseling and follow-up interviews with brief counseling for all the subjects.272 subjects were additionally prescribed Varenicline according to their own choice and reported data were compared to those without Varenicline.Outcomes were self-reported,regarding the 7-day point prevalence on abstinence rate and continuous abstinence rates at 1,3 and 6 month follow-up periods.Results At 6-month and by intention-to-treat,the 7-day point prevalence on abstinence rate with Varenicline and counseling,was significantly higher than the group with counseling only (34.6% versus 23.1% ; OR=1.75,95% CI:1.27-2.42; P<0.001).The 3-month continuous abstinence rate at 6 month was higher in the group with Varenicline (31.3% versus 18.2% ; OR=2.04,95% CI:1.46-2.86; P<0.001).Varenicline also showed better outcomes at 1 and 3 month follow-up.Conclusion Varenicline prescription in the smoking cessation clinic appeared to be effective that doubled the rates of quitting among Chinese smokers in the practice at a community-based SCC.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2014年第12期1349-1353,共5页 Chinese Journal of Epidemiology
基金 国家自然科学基金(81373080) 首都医学发展基金(Z121107001012070) 北京市海淀区科普项目(llkp02006) 英国癌症基金会(C1343/A10155)
关键词 戒烟 吸烟者 药物和心理干预 观察性研究 Smoking cessation Smoker Varenicline and counseling Observational study
  • 相关文献

参考文献2

二级参考文献18

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1052
  • 2杨焱.烟草的危害、流行特点及控制策略[J].中国健康教育,2006,22(5):387-389. 被引量:94
  • 3Yang G,Ma J,Chen A,et al.Smoking cessation in China:findings from the 1996 national prevalence survey Tob Control,2001,10(2):170-174.
  • 4Edwards R,McElduffP,Jenner D,et al.Smoking,smoking cessation,and use of smoking cessation aids and support services in South Derbyshire,England.Public Health,2007,121 (5):321-332.
  • 5Thyrian JR,Panagiotakos DB,Polychronopoulos E,et al.The relationship between smokers' motivation to quit and intensity of tobacco control at the population level:a comparison of five European countries.BMC Public Health,2008,8:2.
  • 6Jiang Y,Ong MK,Tong EK,et al.Chinese physicians and their smoking knowledge,attitudes,and practices.Am J Prev Med,2007,33(1):15-22.
  • 7Lam TH,He Y,Li LS,et al.Mortality attributable to cigarette smoking in China.JAMA,1997,278:1505-1508.
  • 8Chen ZM,Xu Z,Collins R,et al.The early health effects of the emerging tobacco epidemic in China:16-year prospective study.JAMA,1997,278:1500-1504.
  • 9Liu BQ,Peto R,Chen ZM,et al.Emerging tobacco hazards in China:1.Retrospective proportional mortality study of one million deaths.Br Med J,1998,317:1411-1422.
  • 10Lam TH,Li ZB,Ho SY,et al.Smoking,quitting and mortality in an elderly cohort of 56 000 Hong Kong Chinese.Tob Control,2007,16(3):182-189.

共引文献13

同被引文献91

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部